Evogene Ltd. financial data

Symbol
EVGN on Nasdaq
Location
Rehovot, Israel
Fiscal year end
31 December
Latest financial report
20-F - Q4 2024 - 27 Mar 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6,514,589 shares -87%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets $39,864,000 USD -22%
Liabilities $25,026,000 USD 12%